EGM
RCKT icon

Engineers Gate Manager’s Rocket Pharmaceuticals RCKT Stock Holding History

Engineers Gate Manager’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Sell
71,549
-43,619
-38% -$145K ﹤0.01% 1881
2026
Q1 		$412K Buy
115,168
+19,159
+20% +$76.1K 0.01% 1514
2025
Q4 		$337K Buy
96,009
+24,603
+34% +$84.2K ﹤0.01% 1572
2025
Q3 		$233K Sell
71,406
-192,797
-73% -$607K ﹤0.01% 1842
2025
Q2 		$647K Buy
264,203
+243,176
+1,156% +$1.23M 0.01% 1354
2025
Q1 		$140K Buy
+21,027
New +$208K ﹤0.01% 1961

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Engineers Gate Manager's RCKT Position: Q2 2026 in Review

Engineers Gate Manager reduced its Rocket Pharmaceuticals (RCKT) stake by 38% in Q2 2026, selling an estimated $145K and leaving 71,549 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Engineers Gate Manager first reported a position in RCKT in Q1 2025 and has held it in 6 quarters since. The position peaked at $647K in Q2 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Engineers Gate Manager held 71,549 shares of Rocket Pharmaceuticals worth $245K as of Q2 2026.
  • Engineers Gate Manager sold 43,619 Rocket Pharmaceuticals shares in Q2 2026, an estimated $145K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1881 holding.
  • Engineers Gate Manager first reported a position in Rocket Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Engineers Gate Manager's Rocket Pharmaceuticals position peaked at $647K in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.